Vernal keratoconjunctivitis: a major review
- 11 March 2009
- journal article
- review article
- Published by Wiley in Acta Ophthalmologica
- Vol. 87 (2), 133-147
- https://doi.org/10.1111/j.1755-3768.2008.01347.x
Abstract
Vernal keratoconjunctivitis (VKC) is a chronic, bilateral, at times asymmetrical, seasonally exacerbated, allergic inflammation of the ocular surface, involving tarsal and/or bulbar conjunctiva. Though the allergic nature of this entity has been accepted for a long time, the accumulation of a large amount of immunological data has proved that the pathogenesis of VKC is much more complex than a mere type 1 hypersensitivity reaction. In the past several years, many clinical and experimental studies about the cells and mediators involved in initiating and perpetuating the ocular allergic inflammation have shown that T helper type 2 cells and their cytokines, corneal fibroblasts and epithelium along with various growth factors play an important role in the pathogenesis of VKC. Based on this information about the pathogenesis of VKC newer, more selective drugs like anti-chemokine receptor antibodies and leukotriene receptor antagonists are under evaluation. Cyclosporine has been shown to be effective in the treatment of VKC but further randomized control trials are required to establish the minimum effective concentration.This publication has 102 references indexed in Scilit:
- Efficacy and safety of cyclosporine eyedrops in vernal keratoconjunctivitisAnnals of Allergy, Asthma & Immunology, 2002
- Expression of chemokine receptors in vernal keratoconjunctivitisBritish Journal of Ophthalmology, 2001
- A revised nomenclature for allergy: An EAACI position statement from the EAACI nomenclature task forceAllergy, 2001
- Vernal keratoconjunctivitis revisited: A case series of 195 patients with long-term followupOphthalmology, 2000
- Tear levels of interferon‐γ, interleukin (IL) ‐2, IL‐4 and IL‐5 in patients with vernal keratoconjunctivitis, atopic keratoconjunctivitis and allergic conjunctivitisClinical & Experimental Allergy, 2000
- Effects of lodoxamide, disodium cromoglycate and fluorometholone on tear leukotriene levels in vernal keratoconjunctivitisEye, 1998
- Eosinophil cationic protein in tears in allergic conjunctivitis.British Journal of Ophthalmology, 1996
- Eosinophil cationic protein in tears of normal subjects and patients affected by vernal keratoconjunctivitisAllergy, 1995
- Allergic and immunologic disorders of the eyeJournal of Allergy and Clinical Immunology, 1992
- VERNAL KERATOCONJUNCTIVITISInternational Ophthalmology Clinics, 1988